Vivos Inc (RDGL) stock

RDGLOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 9/30

$0.05−0.00 (-2.51%)

Close on Oct 19, 2026Market cap $23.61MP/E –Yield –

Vivos gross margin

Gross margin is gross profit as a percentage of revenue.

Vivos's gross margin for the twelve months ending Sep 30, 2026 was 6.8%. For fiscal 2025 it was -87.4%, against -10.7% the year before. The highest annual figure on record is 100.0% in fiscal 2016.

Annual gross margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	-87.4%	−76.7
FY2024	Dec 31, 2024	-10.7%	+20.3
FY2023	Dec 31, 2023	-31.0%	−52.1
FY2022	Dec 31, 2022	21.2%	+1.8
FY2021	Dec 31, 2021	19.4%	−0.5
FY2020	Dec 31, 2020	19.9%	−16.7
FY2019	Dec 31, 2019	36.5%	−63.5
FY2016	Dec 31, 2016	100.0%	+2.0
FY2015	Dec 31, 2015	98.0%	+2.6
FY2014	Dec 31, 2014	95.4%	+70.3
FY2013	Dec 31, 2013	25.1%	−45.5
FY2012	Dec 31, 2012	70.6%	−13.1
FY2011	Dec 31, 2011	83.7%	+3.2
FY2010	Dec 31, 2010	80.6%	–

Quarterly gross margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q3 FY2026	Sep 30, 2026	74.3%	+756.3
Q2 FY2026	Jun 30, 2026	-4.7%	+227.0
Q1 FY2026	Mar 31, 2026	-22.2%	+11.7
Q4 FY2025	Dec 31, 2025	-12.5%	+93.3
Q3 FY2025	Sep 30, 2025	-682.0%	−703.6
Q2 FY2025	Jun 30, 2025	-231.7%	−251.8
Q1 FY2025	Mar 31, 2025	-34.0%	−0.6
Q4 FY2024	Dec 31, 2024	-105.8%	−205.8
Q3 FY2024	Sep 30, 2024	21.6%	+60.1
Q2 FY2024	Jun 30, 2024	20.1%	+45.7
Q1 FY2024	Mar 31, 2024	-33.3%	+31.7
Q3 FY2023	Sep 30, 2023	100.0%	+200.5
Q2 FY2023	Jun 30, 2023	-38.5%	−119.2
Q1 FY2023	Mar 31, 2023	-25.6%	−102.5
Q4 FY2022	Dec 31, 2022	-65.0%	−124.7
Q3 FY2022	Sep 30, 2022	-100.5%	–
Q2 FY2022	Jun 30, 2022	80.8%	–
Q1 FY2022	Mar 31, 2022	76.9%	–
Q3 FY2021	Sep 30, 2021	59.7%	–